Share Email Print
cover

Proceedings Paper

Imaging efficacy of a targeted imaging agent for fluorescence endoscopy
Author(s): A. J. Healey; R. Bendiksen; T. Attramadal; R. Bjerke; S. Waagene; A. M. Hvoslef; E. Johannesen
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Colorectal cancer is a major cause of cancer death. A significant unmet clinical need exists in the area of screening for earlier and more accurate diagnosis and treatment. We have identified a fluorescence imaging agent targeted to an early stage molecular marker for colorectal cancer. The agent is administered intravenously and imaged in a far red imaging channel as an adjunct to white light endoscopy. There is experimental evidence of preclinical proof of mechanism for the agent. In order to assess potential clinical efficacy, imaging was performed with a prototype fluorescence endoscope system designed to produce clinically relevant images. A clinical laparoscope system was modified for fluorescence imaging. The system was optimised for sensitivity. Images were recorded at settings matching those expected with a clinical endoscope implementation (at video frame rate operation). The animal model was comprised of a HCT-15 xenograft tumour expressing the target at concentration levels expected in early stage colorectal cancer. Tumours were grown subcutaneously. The imaging agent was administered intravenously at a dose of 50nmol/kg body weight. The animals were killed 2 hours post administration and prepared for imaging. A 3-4mm diameter, 1.6mm thick slice of viable tumour was placed over the opened colon and imaged with the laparoscope system. A receiver operator characteristic analysis was applied to imaging results. An area under the curve of 0.98 and a sensitivity of 87% [73, 96] and specificity of 100% [93, 100] were obtained.

Paper Details

Date Published: 22 February 2008
PDF: 12 pages
Proc. SPIE 6867, Molecular Probes for Biomedical Applications II, 68670A (22 February 2008); doi: 10.1117/12.763345
Show Author Affiliations
A. J. Healey, Medical Diagnostics, GE Healthcare Biosciences (Norway)
R. Bendiksen, Medical Diagnostics, GE Healthcare Biosciences (Norway)
T. Attramadal, Medical Diagnostics, GE Healthcare Biosciences (Norway)
R. Bjerke, Medical Diagnostics, GE Healthcare Biosciences (Norway)
S. Waagene, Medical Diagnostics, GE Healthcare Biosciences (Norway)
A. M. Hvoslef, Medical Diagnostics, GE Healthcare Biosciences (Norway)
E. Johannesen, Medical Diagnostics, GE Healthcare Biosciences (Norway)


Published in SPIE Proceedings Vol. 6867:
Molecular Probes for Biomedical Applications II
Samuel Achilefu; Darryl J. Bornhop; Ramesh Raghavachari, Editor(s)

© SPIE. Terms of Use
Back to Top